Old Web
English
Sign In
Acemap
>
Paper
>
FP12.09 Molecular Insight into NADIM Clinical Trial: Potential Immune Biomarkers of Pathological Response for NSCLC Patients.
FP12.09 Molecular Insight into NADIM Clinical Trial: Potential Immune Biomarkers of Pathological Response for NSCLC Patients.
2021
R. Laza-Briviesca
E. Nadal
M. Casarrubios
A Insa
Belen Sierra-Rodero
M. R. Garcia-Campelo
G. Huidobro
M. Dómine Gómez
B. Massuti
Margarita Majem
Delvys Rodriguez Abreu
Alex Martinez Marti
J. De Castro Campeño
M. Cobo Dols
G. Lopez Vivanco
E. del Barco
R Bernabe Caro
Nuria Viñolas
Isidoro Barneto
Santiago Viteri
Alberto Cruz-Bermúdez
M. Provencio
Keywords:
Clinical trial
Medicine
Internal medicine
Oncology
Immune system
pathological response
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]